Cargando…
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease
Alcohol-related liver disease (ALD) is a major cause of liver disease and represents a global burden, as treatment options are scarce. Whereas 90% of ethanol abusers develop alcoholic fatty liver disease (AFLD), only a minority evolves to steatohepatitis and cirrhosis. Alcohol increases lipogenesis...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255095/ https://www.ncbi.nlm.nih.gov/pubmed/35786161 http://dx.doi.org/10.1080/19490976.2022.2089006 |
_version_ | 1784740855307829248 |
---|---|
author | Sangineto, Moris Grander, Christoph Grabherr, Felix Mayr, Lisa Enrich, Barbara Schwärzler, Julian Dallio, Marcello Bukke, Vidyasagar Naik Moola, Archana Moschetta, Antonio Adolph, Timon E. Sabbà, Carlo Serviddio, Gaetano Tilg, Herbert |
author_facet | Sangineto, Moris Grander, Christoph Grabherr, Felix Mayr, Lisa Enrich, Barbara Schwärzler, Julian Dallio, Marcello Bukke, Vidyasagar Naik Moola, Archana Moschetta, Antonio Adolph, Timon E. Sabbà, Carlo Serviddio, Gaetano Tilg, Herbert |
author_sort | Sangineto, Moris |
collection | PubMed |
description | Alcohol-related liver disease (ALD) is a major cause of liver disease and represents a global burden, as treatment options are scarce. Whereas 90% of ethanol abusers develop alcoholic fatty liver disease (AFLD), only a minority evolves to steatohepatitis and cirrhosis. Alcohol increases lipogenesis and suppresses lipid-oxidation implying steatosis, although the key role of intestinal barrier integrity and microbiota in ALD has recently emerged. Bacteroides thetaiotaomicron (Bt) is a prominent member of human and murine intestinal microbiota, and plays important functions in metabolism, gut immunity, and mucosal barrier. We aimed to investigate the role of Bt in the genesis of ethanol-induced liver steatosis. Bt DNA was measured in feces of wild-type mice receiving a Lieber-DeCarli diet supplemented with an increase in alcohol concentration. In a second step, ethanol-fed mice were orally treated with living Bt, followed by analysis of intestinal homeostasis and histological and biochemical alterations in the liver. Alcohol feeding reduced Bt abundance, which was preserved by Bt oral supplementation. Bt-treated mice displayed lower hepatic steatosis and triglyceride content. Bt restored mucosal barrier and reduced LPS translocation by enhancing mucus thickness and production of Mucin2. Furthermore, Bt up-regulated Glucagon-like peptide-1 (GLP-1) expression and restored ethanol-induced Fibroblast growth factor 15 (FGF15) down-regulation. Lipid metabolism was consequently affected as Bt administration reduced fatty acid synthesis (FA) and improved FA oxidation and lipid exportation. Moreover, treatment with Bt preserved the mitochondrial fitness and redox state in alcohol-fed mice. In conclusion, recovery of ethanol-induced Bt depletion by oral supplementation was associated with restored intestinal homeostasis and ameliorated experimental ALD. Bt could serve as a novel probiotic to treat ALD in the future. |
format | Online Article Text |
id | pubmed-9255095 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-92550952022-07-06 Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease Sangineto, Moris Grander, Christoph Grabherr, Felix Mayr, Lisa Enrich, Barbara Schwärzler, Julian Dallio, Marcello Bukke, Vidyasagar Naik Moola, Archana Moschetta, Antonio Adolph, Timon E. Sabbà, Carlo Serviddio, Gaetano Tilg, Herbert Gut Microbes Research Paper Alcohol-related liver disease (ALD) is a major cause of liver disease and represents a global burden, as treatment options are scarce. Whereas 90% of ethanol abusers develop alcoholic fatty liver disease (AFLD), only a minority evolves to steatohepatitis and cirrhosis. Alcohol increases lipogenesis and suppresses lipid-oxidation implying steatosis, although the key role of intestinal barrier integrity and microbiota in ALD has recently emerged. Bacteroides thetaiotaomicron (Bt) is a prominent member of human and murine intestinal microbiota, and plays important functions in metabolism, gut immunity, and mucosal barrier. We aimed to investigate the role of Bt in the genesis of ethanol-induced liver steatosis. Bt DNA was measured in feces of wild-type mice receiving a Lieber-DeCarli diet supplemented with an increase in alcohol concentration. In a second step, ethanol-fed mice were orally treated with living Bt, followed by analysis of intestinal homeostasis and histological and biochemical alterations in the liver. Alcohol feeding reduced Bt abundance, which was preserved by Bt oral supplementation. Bt-treated mice displayed lower hepatic steatosis and triglyceride content. Bt restored mucosal barrier and reduced LPS translocation by enhancing mucus thickness and production of Mucin2. Furthermore, Bt up-regulated Glucagon-like peptide-1 (GLP-1) expression and restored ethanol-induced Fibroblast growth factor 15 (FGF15) down-regulation. Lipid metabolism was consequently affected as Bt administration reduced fatty acid synthesis (FA) and improved FA oxidation and lipid exportation. Moreover, treatment with Bt preserved the mitochondrial fitness and redox state in alcohol-fed mice. In conclusion, recovery of ethanol-induced Bt depletion by oral supplementation was associated with restored intestinal homeostasis and ameliorated experimental ALD. Bt could serve as a novel probiotic to treat ALD in the future. Taylor & Francis 2022-07-03 /pmc/articles/PMC9255095/ /pubmed/35786161 http://dx.doi.org/10.1080/19490976.2022.2089006 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Sangineto, Moris Grander, Christoph Grabherr, Felix Mayr, Lisa Enrich, Barbara Schwärzler, Julian Dallio, Marcello Bukke, Vidyasagar Naik Moola, Archana Moschetta, Antonio Adolph, Timon E. Sabbà, Carlo Serviddio, Gaetano Tilg, Herbert Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease |
title | Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease |
title_full | Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease |
title_fullStr | Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease |
title_full_unstemmed | Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease |
title_short | Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease |
title_sort | recovery of bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255095/ https://www.ncbi.nlm.nih.gov/pubmed/35786161 http://dx.doi.org/10.1080/19490976.2022.2089006 |
work_keys_str_mv | AT sanginetomoris recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease AT granderchristoph recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease AT grabherrfelix recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease AT mayrlisa recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease AT enrichbarbara recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease AT schwarzlerjulian recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease AT dalliomarcello recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease AT bukkevidyasagarnaik recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease AT moolaarchana recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease AT moschettaantonio recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease AT adolphtimone recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease AT sabbacarlo recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease AT serviddiogaetano recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease AT tilgherbert recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease |